Abingdon Health (LON:ABDX) Trading Down 4.7%

Abingdon Health Plc (LON:ABDX – Get Rating)’s stock price was down 4.7% on Wednesday . The stock traded as low as GBX 5.01 ($0.06) and last traded at GBX 5.01 ($0.06). Approximately 73,317 shares were traded during trading, a decline of 76% from the average daily volume of 305,533 shares. The stock had previously closed at GBX 5.25 ($0.06).

Abingdon Health Price Performance

The company has a current ratio of 2.06, a quick ratio of 1.96 and a debt-to-equity ratio of 19.90. The firm has a market cap of £6.09 million, a P/E ratio of -71.50 and a beta of 0.16. The company has a fifty day moving average price of GBX 5.20 and a two-hundred day moving average price of GBX 5.70.

About Abingdon Health

(Get Rating)

Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices worldwide. The company offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; PCRD and PCRD FLEX, nucleic acid lateral flow tests used for rapid readouts post isothermal amplification; Abingdon Simply Test, a range of self-tests; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2.